Cargando…
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the deterioration of motor neurons. However, this complex disease extends beyond the boundaries of the central nervous system, with metabolic alterations being observed at the systemic and cellular level. While the...
Autores principales: | Kirk, Siobhan E., Tracey, Timothy J., Steyn, Frederik J., Ngo, Shyuan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431787/ https://www.ncbi.nlm.nih.gov/pubmed/30936848 http://dx.doi.org/10.3389/fneur.2019.00191 |
Ejemplares similares
-
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
por: Tefera, Tesfaye Wolde, et al.
Publicado: (2021) -
Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023) -
Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019) -
Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019) -
Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions
por: Ngo, Shyuan T, et al.
Publicado: (2017)